Wells Fargo & Company MN lowered its stake in shares of Exponent, Inc. (NASDAQ:EXPO) by 2.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 68,492 shares of the business services provider’s stock after selling 1,403 shares during the period. Wells Fargo & Company MN owned 0.26% of Exponent worth $3,993,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of the business. BlackRock Inc. lifted its holdings in Exponent by 41,234.4% during the first quarter. BlackRock Inc. now owns 3,080,242 shares of the business services provider’s stock worth $183,428,000 after buying an additional 3,072,790 shares during the period. Vanguard Group Inc. lifted its holdings in Exponent by 3.9% during the first quarter. Vanguard Group Inc. now owns 2,176,141 shares of the business services provider’s stock worth $129,590,000 after buying an additional 81,811 shares during the period. Conestoga Capital Advisors LLC lifted its holdings in Exponent by 15.6% during the second quarter. Conestoga Capital Advisors LLC now owns 727,177 shares of the business services provider’s stock worth $42,394,000 after buying an additional 98,280 shares during the period. State Street Corp lifted its holdings in Exponent by 7.1% during the first quarter. State Street Corp now owns 614,266 shares of the business services provider’s stock worth $36,583,000 after buying an additional 40,833 shares during the period. Finally, GW&K Investment Management LLC lifted its holdings in Exponent by 20.4% during the second quarter. GW&K Investment Management LLC now owns 407,557 shares of the business services provider’s stock worth $23,761,000 after buying an additional 68,938 shares during the period. Institutional investors own 88.29% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Wells Fargo & Company MN Has $3.99 Million Holdings in Exponent, Inc. (EXPO)” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this story on another site, it was copied illegally and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this story can be read at https://www.thecerbatgem.com/2017/10/16/wells-fargo-company-mn-has-3-99-million-holdings-in-exponent-inc-expo.html.

Exponent, Inc. (EXPO) opened at 75.15 on Monday. Exponent, Inc. has a 12 month low of $48.72 and a 12 month high of $76.20. The firm has a market capitalization of $1.94 billion, a P/E ratio of 38.96 and a beta of 0.61. The stock’s 50 day moving average price is $71.86 and its 200-day moving average price is $63.75.

Exponent (NASDAQ:EXPO) last issued its quarterly earnings results on Tuesday, July 18th. The business services provider reported $0.51 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.41 by $0.10. Exponent had a net margin of 15.94% and a return on equity of 16.52%. The company had revenue of $84.10 million during the quarter, compared to analysts’ expectations of $79.30 million. During the same quarter last year, the company posted $0.38 EPS. The firm’s revenue was up 14.7% compared to the same quarter last year. Equities analysts forecast that Exponent, Inc. will post $1.97 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 22nd. Stockholders of record on Friday, September 1st were given a dividend of $0.21 per share. The ex-dividend date was Wednesday, August 30th. This represents a $0.84 annualized dividend and a dividend yield of 1.12%. Exponent’s dividend payout ratio (DPR) is currently 43.52%.

A number of analysts have weighed in on EXPO shares. BidaskClub lowered Exponent from a “hold” rating to a “sell” rating in a report on Tuesday, June 20th. Zacks Investment Research lowered Exponent from a “buy” rating to a “hold” rating in a report on Tuesday, July 11th. Cantor Fitzgerald restated a “buy” rating and set a $75.00 target price (up previously from $69.00) on shares of Exponent in a report on Wednesday, July 19th. Finally, ValuEngine upgraded Exponent from a “sell” rating to a “hold” rating in a report on Thursday, July 20th.

In other news, insider Harri Kytomaa sold 12,000 shares of Exponent stock in a transaction on Friday, August 4th. The shares were sold at an average price of $66.38, for a total transaction of $796,560.00. Following the completion of the sale, the insider now directly owns 11,360 shares of the company’s stock, valued at approximately $754,076.80. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider John Pye sold 3,600 shares of Exponent stock in a transaction on Monday, July 24th. The stock was sold at an average price of $65.08, for a total transaction of $234,288.00. Following the sale, the insider now directly owns 14,767 shares of the company’s stock, valued at $961,036.36. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 80,848 shares of company stock valued at $5,425,477. Corporate insiders own 2.80% of the company’s stock.

Exponent Company Profile

Exponent, Inc (Exponent), along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project-by-project basis. It operates in two segments: Engineering and Other Scientific, and Environmental and Health.

Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO).

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Receive News & Stock Ratings for Exponent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent Inc. and related stocks with our FREE daily email newsletter.